Fosamax  is a prescription medicine for the prevention of osteoporosis in postmenopausal women, for treatment of osteoporosis in postmenopausal women, for increasing bone mass in men with osteoporosis, for men and women with low bone mass who take glucocorticoidsAlso, Fosamax for treatment of Paget’s disease of bone in both men and women.

FFosamax for treatment of Osteoporosis. It is an aminobisphosphonate that binds to bone hydroxyapatite and specifically inhibits the activity of osteoclasts, the bone-resorbing cells. Fosamax reduces bone resorption with no direct effect on bone formation, although the latter process is ultimately reduced because bone resorption and formation are coupled during bone turnover. Fosamax thus reduces the elevated rate of bone turnover observed in postmenopausal women to approximate more closely that in premenopausal women. Fosamax is not an estrogen and does not have the benefits and risks of estrogen replacement therapy. Fosamax for treatment of Osteoporosis

You should not use Fosamax if you have certain disorders of the esophagus (the tube connecting the mouth with the stomach), are not able to stand or sit upright for 30 minutes, have severe kidney disease, low blood calcium, or are allergic to FOSAMAX. In addition, if you have difficulty swallowing liquids you should not take FOSAMAX oral solution. Before use, talk to your doctor if you have stomach or digestive problems. Fosamax for treatment of Osteoporosis

Fosamax for treatment of Osteoporosis